45th Annual Meeting of the Swiss Society of Biological Psychiatry (SSBP)

[Translate to English:] Leo SSBP November 2026

5. November 2026

The 45th Annual Meeting of the Swiss Society of Biological Psychiatry (SSBP) took place at the University Psychiatric Clinics Basel under the theme “Brain Energy and Immunity – from Cells to Circuits”. The congress brought together national and international researchers and clinicians to discuss recent advances in biological psychiatry, with a particular focus on the interactions between brain and body and their implications for psychiatric diagnosis and treatment.

Leonhard Kempinger presented his research on ABCB1 genotyping in depression treatment, highlighting its role in personalised antidepressant therapy. The poster presentation provided an opportunity to share his research with experts from different fields, exchange ideas and receive feedback from the scientific community.

Biopharmacy at the 27th ISSX North American Meeting in San Francisco

[Translate to English:] Leila ISSX SF 2026

11-14 October 2026

PhD candidate Leila Potzel represented the Biopharmacy group at the 27th ISSX North American Meeting, held in San Francisco, USA, from 11th to 14th of October 2026. The meeting brought together scientists from academia, industry and regulatory agencies to discuss the latest advances in drug metabolism, drug transporters and pharmacokinetics.

Leila is currently on a research stay at the Eshelman School of Pharmacy at the University of North Carolina at Chapel Hill (1 June to 30 November 2026), where she is gaining expertise in quantitative proteomics and applying it to placental tissue samples. At the meeting, she presented her research entitled “Coproporphyrin I as an Endogenous Biomarker Across Early Life: Impact of Placental Transporter Expression and Genetic Variation,” a collaboration between the University of Basel, the University Children’s Hospital Basel and UNC Chapel Hill.

A particular highlight was the selection of her abstract for a rapid fire talk in the Transporters Focus Group session, in addition to her poster presentation. Both led to valuable discussions and feedback from experts in the field.

The meeting also offered an excellent opportunity to connect with the international DMPK community and to further strengthen the collaboration with UNC Chapel Hill.

Industry Day at Idorsia

[Translate to English:] Industry Day Idorsia

21 September 2026

Members of the Biopharmacy group joined the Industry Day at Idorsia on 21 September 2026. During the career event organized by the PhD representatives at the DPhW, Tzu-Ya Hung, Nikolaos Paloumpis and Dr. Marta Rysz explored different areas of drug discovery, including omics, high-throughput screening, medicinal chemistry, and computer-aided drug design (CADD). Researchers at Idorsia introduced them to their work and explained how their teams contribute to the development of new medicines.

Furthermore, they had the opportunity to meet colleagues working in Project Management, Patent Counsel, and Medical Affairs and learned more about their roles and career paths. Lunch gave them time to continue the conversations and get to know the people behind the research.

Scientific Exchange at the Swiss Pharma Science Day 2026 in Bern

[Translate to English:] Swiss Pharma Science Day 2026

20 August 2026

All members of the Biopharmacy group attended the 19th Swiss Pharma Science Day (SPhSD), held in Bern, Switzerland and organized by the Swiss Academy of Pharmaceutical Sciences (SAPhS). This annual event brings together researchers, students, and professionals from academia and industry to exchange scientific knowledge and explore recent developments in pharmaceutical sciences. 

This year, the focus of the meeting was “Women’s Health and Gender Medicine”, emphasizing the importance of considering sex- and gender-related differences in medical research and treatment. The scientific program covered a wide variety of topics, including endometriosis, sex-dependent treatment effects, drug delivery strategies for maternal and fetal health, and gender-sensitive approaches in pharmacy practice. In addition to the scientific talks, the poster session gave us an opportunity to present and discuss our research. Leonhard Kempinger, Tzu-Ya Hung and Nikolaos Paloumpis presented their ongoing projects and exchanged ideas with researchers from different areas of pharmaceutical sciences. The meeting also provided opportunities to connect with colleagues and researchers from academia and industry.

Overall, the Swiss Pharma Science Day was a great experience for the Biopharmacy group to share our research, learn about other projects and connect within the Swiss pharmaceutical research community.

Scientific Exchange and Recognition at the 16th European ISSX Meeting in Basel

[Translate to English:] ISSX 2026 heller

29 June 2026

All PhD candidates and the Postdoctoral researcher from the Biopharmacy group attended the 16th European ISSX Meeting, held in Basel, Switzerland, from 29 June to 2 July 2026. As this international meeting takes place in a different location each year, its organization in Basel provided a unique opportunity for the entire Biopharmacy team to participate together in this international event in the field. The conference brought together leading experts from academia and industry to exchange the latest advances in drug metabolism and pharmacokinetics (DMPK) and their implementation in modern drug development. The meeting covered emerging topics in drug metabolism and pharmacokinetics, including model-informed drug development, AI applications in ADME sciences, and challenges associated with novel therapeutic modalities. Beyond the scientific sessions, the meeting offered an excellent opportunity to exchange ideas with leading experts in the field, connect with the international DMPK community, and meet several long-standing collaborators in person. These interactions enabled discussions on ongoing projects and future research directions, fostering new ideas and strengthening existing collaborations. 

A particular highlight for the group was the recognition of Dr. Marta Rysz, who was awarded Third Place in the ISSX Postdoctoral Fellows Poster Awards Competition for her poster presentation, acknowledging the high quality and impact of her research.

Master students 2026

[Translate to English:] Master students Biopharmacy 2026

12 June 2026

The Biopharmacy group offers interested students the opportunity to conduct their Master’s thesis projects in our laboratory each year. These projects provide selected students with first-hand insights into experimental wet-lab research and day-to-day scientific work. The thesis topics are closely aligned with the research projects of our postdoctoral and PhD researchers, ensuring strong scientific integration and dedicated supervision, often in an almost one-to-one mentoring setting. This structure allows students to actively contribute to ongoing research while receiving continuous guidance and support throughout their project.

This year’s Master’s students, Jeron David Antony, Bleona Tahiri, Mascha Bögli, Ramon Jacobs, Diyar Dumaz, Pascal Odermatt (from left to right in the photo), successfully completed their Master’s thesis work in June 2026 within the Biopharmacy group at the Department of Pharmaceutical Sciences as part of the Master of Pharmacy program.

The past months were marked by intensive work, exciting projects, and many important contributions to our mission in research and education.

For us as the Biopharmacy Team, the collaboration with them was both professionally and personally enriching. We sincerely thank them for the great teamwork and hope that their time in our laboratory and team was both educational and rewarding, providing valuable experiences for their future careers. We also hope that this experience may inspire some of them to pursue a future in the broad field of pharmaceutical science.

Leila Potzel awarded Doc.Mobility Fellowship – Research Stay at UNC

[Translate to English:] Bild Leila Abflug 2026

1 June 2026

Leila Potzel, PhD-student within the Biopharmacy has been awarded a competitive Doc.Mobility fellowship, enabling her to undertake a research stay at the Eshelman School of Pharmacy, University of North Carolina (UNC) at Chapel Hill within the framework of the project “Investigating placental mechanisms for feto-maternal coproporphyrin exchange” in collaboration with Prof. Jacqueline B. Tiley and Prof. Kim L.R. Brouwer. Following the approval in November 2025, she carefully prepared for this next step, including the organization of administrative matters as well as the completion of her teaching and research responsibilities.

With great motivation and anticipation, she set out for the United States in June 2026 to begin this valuable academic and personal experience. During her stay, she will further develop her research in an international environment, build on her already broad network of active collaborations, gain insights into new methodological approaches, and expand her scientific network even further.

While she will certainly be missed by the team, we warmly congratulate her on this outstanding opportunity and fully support her during this important stage of her academic career.

Upon her return, Leila will enrich the Department of Pharmaceutical Sciences with fresh perspectives, advanced methodological insights, and international experience gained abroad, contributing to both research and teaching.

Active participation at the Pint of Science Event 2026

[Translate to English:] Picture Pint of Science Event 2026

18 May 2026

Pint of Science is an international science communication festival with the mission of bringing researchers and the public together in an informal and accessible setting. By moving scientific discussions out of the laboratory and into cafés, pubs, and public venues, the initiative aims to make science approachable, engaging, and open to everyone.

On May 18 2026, three members of the department participated in the Pint of Science event in Basel at the Novartis Pavillon, where they presented their research to a mixed audience in a relaxed and welcoming atmosphere.

The evening featured three talks, two of which were presented by members of the department: “Predicting Your Drug Response … One Bite at a Time” by Dr. Marta Rysz and Nikolaos Paloumpis, and “Trips, Traces and Neuronal Communication” by Prof. Dr. Linda Simmler.

Both presentations sparked lively discussions and an exciting Q&A session with the audience. The cozy setting of the event created the perfect environment for open scientific exchange and inspiring conversations.

Leonhard Kempinger presents at the 6th Joint Congress of the AGNP and DGBP 2026

[Translate to English:] Bild 3 Leo 2026 Berlin

7 May 2026

Leonhard Kempinger, a PhD student in Biopharmacy who has just started his second year, participated in the 6th Joint Congress of the AGNP and DGBP 2026, where he contributed to a symposium organized by the Swiss Society of Biological Psychiatry entitled “Biomarkers for Therapy Optimisation”.

He delivered his first presentation at a scientific conference on 7 May 2026. His talk, entitled “ABCB1 Genotypisierung zu Präzisionstherapie: Reloaded?”, took place in a well-attended session and provided an excellent basis for lively exchange with researchers from various disciplines.

He presented data from a translational research project carried out in close collaboration with Prof. Thorsten Mikoteit. The discussion that followed was characterized by strong interest in his work and offered valuable feedback from an international scientific audience. These insights are now being incorporated into the final stages of the project and its ongoing completion.

To top